Facilitative glucose transporter-1 (GLUT1) is abundant in trophoblast cells and is responsible for glucose transport in the placenta. However, the change in GLUT expression in human placenta upon trophoblast differentiation remains to be clarified. Therefore, we first examined the localization of GLUT1 and GLUT3 using human firsttrimester chorionic villi. We found that GLUT1 and GLUT3 were mainly localized to syncytiotrophoblast and cytotrophoblast cells respectively. We analyzed whether placental GLUT1 and GLUT3 expression changes during differentiation using a human choriocarcinoma (BeWo) cell line which is known to show functional and morphological differentiation in response to cAMP in culture. Treatment of BeWo cells with 8-bromocyclicAMP (8-bromo-cAMP) increased the level of hCG secretion and induced cell fusion leading to the formation of large syncytia. Treatment of BeWo cells with 8-bromocAMP also resulted in a significant increase in glucose uptake on days 2-3 of culture. The stimulating effect of 8-bromo-cAMP on glucose uptake was concentration dependent. Northern and immunoblot analyses revealed that the levels of mRNA and protein of GLUT1, but not of GLUT3, were significantly increased by 8-bromocAMP. These findings suggest that 8-bromo-cAMP stimulates GLUT1 expression with differentiation in BeWo cells.
Introduction
Glucose transferred from the maternal blood to the fetal circulation is a major energy source and placental glucose transport is mediated by Na + -independent facilitated diffusion along a concentration gradient (Baly & Horuk 1988) . This mechanism depends on the cellular membrane proteins belonging to the family of facilitative glucose transporters (GLUTs) which show a tissue-specific distribution (Hahn & Desoye 1996) . For example, GLUT1 is abundant on the plasma membranes of the cells composing the blood-tissue barriers, such as in the brain and the placenta (Mueckler et al. 1985 . GLUT3 is abundant in organs with high glucose requirements such as the human brain (Gould et al. 1991 , Haber et al. 1993 and placenta ). GLUT3 mRNA was reported to be expressed in human and rat placenta ). However several reports failed to demonstrate that GLUT3 protein is expressed in human term placenta (Maher et al. 1992 , Jansson et al. 1993 , Barros et al. 1995 .
In human trophoblast cells, cAMP has been shown to stimulate functional differentiation: it stimulates human chorionic gonadotropin (hCG) secretion (Feinman et al. 1986) . Another study showed that cAMP stimulated morphological differentiation: it stimulated cell fusion or syncytiotrophoblast formation from mononuclear cytotrophoblast-like cells in a human choriocarcinoma (BeWo) cell line (Wice et al. 1990) .
However, the changes in placental GLUT1 and GLUT3 expression during trophoblast differentiation remain to be elucidated. In this study, we first performed immunohistochemical experiments to investigate the localization of GLUT1 and GLUT3 using human chorionic villi. Next, in order to investigate whether the amounts of GLUT1 and GLUT3 in BeWo cells change with 8-bromo-cAMP-induced differentiation, we performed the 2-deoxyglucose uptake experiment, Northern and immunoblot analyses.
Materials and Methods
Chemicals 8-Bromo-cAMP, cholera toxin, forskolin, ethylenediamine tetra-acetate (EDTA), aprotinin, leupeptin, soybean trypsin inhibitor and phenylmethylsulfonyl fluoride (PMSF) were obtained from Sigma (St Louis, MO, USA). 
Laser scanning confocal microscopy
Normal human chorionic villi in the eighth week of pregnancy were sectioned to investigate the localization of GLUT1 and GLUT3. The tissue specimens were fixed for 3 h at 4 C with 4% paraformaldehyde and 0·5% glutaraldehyde in 0·1 mol/l phosphate buffer and then with 4% paraformaldehyde in 0·1 mol/l phosphate buffer overnight at 4 C. Next, they were soaked overnight at 4 C in 15% sucrose in 0·1 mol/l phosphate buffer. Cryostat sections (8 µm) were cut and incubated with anti-GLUT1 (1:300) and anti-GLUT3 (Charles River Laboratories, Southbridge, MA, USA) (1:50) antibodies raised in rabbits overnight at 4 C. The GLUT1 antibody was prepared by immunizing rabbits with synthesized peptides corresponding to residues 215-226 predicted from the cDNA of human GLUT1 (Mueckler et al. 1985) . This antibody also recognizes human placental GLUT1 protein on immunoblot analysis . The anti-GLUT3 rabbit antibody, which recognizes the 12 amino acid synthetic peptide corresponding to the carboxy terminus of the human GLUT3 sequence, reacts only with GLUT3 in human brain (Mantych et al. 1992) and with human tumor cell lines (Harris et al. 1992) . After the incubation with biotinylated anti-rabbit goat immunoglobulin G (IgG; 1:500) for 2 h at room temperature, the sections were exposed to fluorescein isothiocyanate (FITC)-conjugated streptavidin (1:100) for 1 h at room temperature. Finally, the sections were embedded in 50% glycerin, and the immunohistochemical localization of GLUT1 and GLUT3 were examined using a Bio-Rad MRC-600 laser scanning confocal microscope (LSCM; Bio-Rad, Richmond, CA, USA).
Cell culture
BeWo cells, mononuclear cytotrophoblast-like cells of the human choriocarcinoma cell line, were obtained from Health Science Research Resources Bank (Osaka, Japan). Cells were maintained in a culture medium (Ham's F12K with 0·12% NaHCO 3 , pH 7·4, 50 mg/l streptomycin, 50 kU/l penicillin G) containing 15% fetal calf serum (FCS) under an atmosphere of 95% air/5% CO 2 at 37 C. At confluency, cells were treated with 0·02% EDTA and 0·25% trypsin and detached cells were transferred to new flasks at a density of 1 10 4 cells/cm 2 . The trypsinized cells were plated in multi-well plates at a density of 2 10 5 cells/cm 2 , and maintained in culture medium containing 15% FCS. Two days after confluency, the medium was replaced with serum-free medium, and 8-bromo-cAMP, cholera toxin, forskolin or the vehicle (control group) was added. The medium was changed daily.
Giemza staining of BeWo cells
After incubation in the absence or presence of 250 µmol/l cAMP for 48 h in serum-free medium, cells were washed with phosphate-buffered saline (PBS) for 2 min. Cells were treated with Giemza stain solution (Nacalai Tesque, Inc, Kyoto, Japan) for 2 h and then washed twice with PBS. The morphology of cells was examined under a light microscope ( 400).
Measurement of hCG in the medium
The concentration of hCG in the medium was determined by RIA using a polyclonal antibody against hCG (Biogenesis Ltd, Poole, UK). The antibody showed crossreactivity as follows: hCG 100%, hLH 16%, hCG 4·1%, hCG 0·2%. The sensitivity of the assay was 50 µIU/l hCG.
Measurement of 2-deoxyglucose uptake
Uptake of 2-[ 3 H]deoxyglucose, a non-metabolizable analogue of glucose, was measured in BeWo cells plated in 24-well plates as described (12 wells per group) . Each experiment was repeated twice with similar results and representative results are shown. After removing the medium, the cells were washed three times with 1·0 ml prewarmed PBS and incubated in 1·0 ml prewarmed transport buffer containing 25 mmol/l HEPES, pH 7·4, 0·8 mmol/l MgSO 4 , 140 mmol/l NaCl, 5·4 mmol/l KCl, 1·8 mmol/l CaCl 2 , and 1 mCi/l 2-[ 3 H]deoxyglucose (1 µmol/l) at 37 C for 10 min. To terminate 2-[ 3 H]deoxyglucose uptake, the buffer containing 2-[ 3 H]deoxyglucose was removed and rapidly washed three times with ice-cold transport buffer. The incorporation of the radioactivity into the cells was linear during the time period (data not shown). The cells were solubilized in 0·6 ml of 0·03% sodium dodecyl sulfate (SDS), and 0·4 ml aliquots were counted in a liquid scintillation counter. A 0·1 ml aliquot was used to determine the protein concentration using a detergent compatible protein assay kit (Bio-Rad). Non-carrier-mediated uptake of 2-deoxyglucose was determined in parallel wells containing either 10 µmol/l cytochalasin B or 100 mmol/l -glucose.
Measurement of serotonin and leucine uptake
Serotonin uptake was studied as described previously . Cells were incubated for 45 min at room temperature prior to the measurement of serotonin uptake with a buffer containing 25 mmol/l HEPES, pH 7·5, 0·8 mmol/l MgSO 4 , 140 mmol/l NaCl, 5·4 mmol/l KCl, 1·8 mmol/l CaCl 2 , 5 mmol/l -glucose and 0·1 mmol/l iproniazid (transport buffer). After the incubation, serotonin uptake was studied by adding 1 ml transport buffer containing 50 nmol/l radiolabeled serotonin. After 20 min incubation, the radioactive buffer was removed and each well was rapidly washed three times with transport buffer containing 0·1 mmol/l imipramine. Cells were solubilized and the radioactivity incorporated into the cells was counted as described above.
Leucine uptake was studied using a procedure similar to that described above except that the step of preincubation with iproniazid was omitted and the washing buffer did not contain imipramine. Serotonin and leucine uptake was measured in 12 wells per group in each experiment on BeWo cells plated in 24-well plates. Each experiment was repeated twice.
Northern blot analysis
Total RNA was prepared from cells cultured in the absence or presence of 250 µmol/l 8-bromo-cAMP for 2 days as described (Chomczynski & Sacchi 1987) . Northern blot analysis was performed as described previously (Chen et al. 1988 , Sakata et al. 1992 . In brief, 20 µg total RNA was denatured and electrophoresed on a 1% agarose/0·66 mol/l formaldehyde gel and blotted onto a nylon membrane filter (Zeta-Probe; Bio-Rad). The filter was hybridized in 0·25 mol/l NaPHO 4 (pH 7·2), 0·25 mol/l NaCl, 7% SDS, 1 mol/l EDTA and 50% formamide for 18 h at 43 C in medium containing 2 10 6 c.p.m./ml 32 P-labeled rabbit GLUT1 . The coding region of rabbit GLUT1 cDNA shared 93·2 and 89·4% nucleotide homology with human (Mueckler et al. 1985) and rat (Birnbaum et al. 1986 ) glucose transporter respectively. The filter was washed and autoradiographed for 2 days at -80 C. Then the filter was stripped, rehybridized with 32 P-labeled human GLUT3 cDNA probe ) and autoradiographed for 3 days at 80 C. The band intensities were analyzed with a densitometer (Imaging Research Inc., St Catharines, Ontario, Canada) and the amounts of GLUT1 and GLUT3 mRNA were divided by those of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA (Bosma & Kooistra 1991) .
Immunoblot analysis
Cells incubated in the absence or presence of 250 µmol/l 8-bromo-cAMP for 2 days were washed with Ham's F12K medium and treated as described previously . After a treatment with detachment buffer (250 mmol/l sucrose, 10 mmol/l Tris, pH 7·4, 1 mmol/l EDTA, 0·3 mmol/l PMSF, 1 mg/l each pepstatin and leupeptin), cells were scraped off the plates, collected by centrifugation at 12 000 g at 4 C for 10 min, and solubilized with 1% Triton X-100. After preparation of cell membrane, aliquots were denatured with an equal amount of buffer containing 200 mmol/l dithiothreitol (DTT), 20% glycerol, 0·04% bromophenol blue, 10% SDS and 120 mmol/l Tris-HCl (pH 6·8) at 60 C for 15 min to avoid aggregation of GLUT proteins (Morita et al. 1992) . Protein concentration was measured using the Bradford method (Bradford 1976) . Denatured samples (50 µg) were subjected to 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli 1970) , and transferred to a nitrocellulose filter (Wilson et al. 1984 ) (Bio-Rad). In the parallel experiment, we checked whether the protein samples were equally transferred to a nitrocellulose filter with staining of the filter by ponceau S solution (Sigma). The filter was incubated with a rabbit anti-GLUT1 antiserum or with a rabbit anti-GLUT3 antiserum (Charles River Laboratories) at a dilution of 1:3000 or 1:1000 respectively. Then, the filter was incubated with goat anti-rabbit IgG conjugated to horseradish perioxidase (Bio-Rad) at a dilution of 1:3000. The filter was stained with an enhanced chemiluminescent (ECL) system (Amersham) and exposed to a Kodak X-Omat film (Kodak, Rochester, NY, USA) for 15 s. The band intensities were analyzed as described above.
Statistical methods
Data were expressed as means ..M., and were statistically analyzed using the analysis of variance followed by Student's unpaired t-test or Scheffé's multiple range test. Statistical significance was determined at P<0·05.
Results
To examine the localization of GLUT1 and GLUT3 in human chorionic villi at 8 weeks of gestation, confocal immunofluorescence microscopy was performed using rabbit anti-GLUT1 and rabbit anti-GLUT3 antisera. We found that GLUT1 and GLUT3 were mainly localized to the plasma membrane of the syncytiotrophoblasts and the cytotrophoblasts respectively (Fig. 1) . When sections were incubated with normal rabbit serum instead of the specific primary antibody, no positive staining was observed (data not shown).
To ascertain whether placental GLUT1 and GLUT3 expression changes during trophoblast differentiation, we carried out experiments using BeWo cells which are known to be differentiated by cAMP. Light microscopy using Giemsa staining revealed the presence of several multi-nuclear syncytiotrophoblast cells, which were larger than the cytotrophoblast cells after treatment with 250 µmol/l 8-bromo-cAMP for 2 days (data not shown). In addition, the level of hCG secretion after treatment with 250 µmol/l 8-bromo-cAMP was significantly higher than that of the control from day 1 through 5 of culture (Fig. 2) . These findings suggest that 8-bromo-cAMP is an important promoter of morphological and functional differentiation in BeWo cells.
Incubation of BeWo cells with 250 µmol/l 8-bromo-cAMP significantly (P<0·01) increased the 2-deoxyglucose uptake on days 2 and 3 of culture (Fig. 3) . Figure 4 shows that the stimulating effect by 8-bromocAMP was dose dependent and that the lowest effective concentration was 63 µmol/l. Next, to study whether an increase in the intracellular cAMP level shows a similar effect to 8-bromo-cAMP treatment on the 2-deoxyglucose uptake, we incubated BeWo cells with cholera toxin and forskolin. Incubation of BeWo cells with cholera toxin or forskolin for 2 days also resulted in a significant (P<0·01) increase in 2-deoxyglucose uptake compared with the control (Fig. 5) .
To ascertain whether the stimulating effect of 8-bromocAMP on 2-deoxyglucose uptake in BeWo cells is specific, the effect of 8-bromo-cAMP on leucine (Na + -independent active transport) and serotonin (Na + -dependent active transport) uptake was examined. Incubation of BeWo cells with 250 µmol/l 8-bromo-cAMP for 2 days did not produce a significant change in leucine or serotonin uptake (data not shown). These findings suggest that the transport of glucose, but not leucine or serotonin, in BeWo cells is stimulated by 8-bromo-cAMP.
To study whether the increase in 2-deoxyglucose uptake in BeWo cells was due to the increase in GLUT expression, we analyzed the changes in steady-state GLUT1 and GLUT3 mRNA levels by Northern blot analyses. BeWo cells were incubated in the absence or presence of 250 µmol/l 8-bromo-cAMP for 2 days, and total RNA samples were extracted. Hybridization with a 32 P-labeled GLUT1 cDNA probe yielded a single band at approximately 2·8 kb (Fig. 6) . The amounts of GLUT1 mRNA were divided by those of G3PDH mRNA. The normalized GLUT1 band intensity of the 8-bromo-cAMP-treated group was significantly (P<0·01) higher than that of the controls (normalized band intensity (in arbitrary units): control, 0·18 0·02; 8-bromo-cAMP, 0·39 0·04). The filter was rehybridized with 32 P-labeled GLUT3 cDNA. The GLUT3 mRNA was detected at 4·1 and 2·7 kb (Fig. 6) . The GLUT3 mRNA level in the 8-bromo-cAMP-treated group did not show a significant difference compared with that of the controls (normalized band intensity (in arbitrary units): control, 1·01 0·27; 8-bromo-cAMP, 1·05 0·17). To examine the effect of 8-bromo-cAMP on the GLUT1 and GLUT3 protein levels, we performed immunoblot analysis using specific antisera against GLUT1 and GLUT3, which mainly recognized 49 and 47 kDa proteins respectively in BeWo cells (Fig. 7) . In immunoblot analysis (Fig. 7) , the bands of both GLUT1 and GLUT3 were diffuse. A previous study using immunoblot analysis for human placental GLUT1 with the same antibody revealed a major band at 49 kDa, a minor band at 60 kDa and a faint band between these two (Sakata et al. 1995) and these made a diffuse band in an immunoblot analysis. One possible reason for the different molecular mass on SDS-PAGE is that these protein bands represent GLUT with different levels of glycosylation (Takata et al. 1990) . When the filter was incubated with a non-immune serum, no specific bands were observed (data not shown). BeWo cells were incubated in the absence or presence of 250 µmol/l 8-bromocAMP for 2 days, and solubilized fractions of cells were obtained. The GLUT1 protein level in the 8-bromocAMP-treated group was significantly (P<0·01) higher than that of the controls (normalized band intensity (in arbitrary units): control, 0·52 0·03; 8-bromo-cAMP, 0·73 0·09). In contrast, the GLUT3 protein level in the 8-bromo-cAMP-treated group did not show a significant difference compared with that of the control (normalized band intensity (in arbitrary units): control, 0·25 0·02; 8-bromo-cAMP, 0·23 0·01).
Discussion
The human placental structure changes during pregnancy: the multinuclear syncytiotrophoblasts, which differentiate from the mononuclear cytotrophoblasts, accumulate and are the most abundant in the term placenta (Benirschke & Kaufmann 1990) . We previously reported that GLUT1 mRNA and protein levels in human placenta increased during pregnancy, whereas the expression level of placental GLUT3 mRNA was highest in early gestation, and decreased markedly in the mid-and fullterm placenta (Sakata et al. 1995) . Confocal microscopy revealed that specific staining for GLUT1 seemed to be localized both in syncytiotrophoblasts and in cytotrophoblasts (Fig. 1) . However, immunoelectron microscopic analysis revealed little specific staining for GLUT1 in the cytotrophoblasts . At the light microscopic level, the cytotrophoblasts were often surrounded by syncytiotrophoblast cell membrane showing GLUT1 immunoreactivity. Furthermore, the immunohistochemical results (Fig. 1) show that GLUT3 was mainly localized to the cytotrophoblasts. These observations enable us to speculate that the placental expression of GLUT1 increases, while that of GLUT3 decreases during placental differentiation and that the changes in the levels of GLUT1 and GLUT3 are possible markers of trophoblast differentiation.
In a previous study, mononuclear cytotrophoblasts aggregated and fused to form syncytial structures with a concomitant increase in cellular levels of cAMP. This enhanced the expression of genes representative of syncytiotrophoblast endocrine activity (Kao et al. 1992) . It is also reported that treatment with 8-bromo-cAMP causes cytotrophoblasts isolated from term placenta to aggregate within hours and an increase in hCG and progestin secretion in serum-supplemented medium (Feinman et al. 1986 ). Moreover, Wice et al. (1990) showed that BeWo cells underwent fusion and morphological differentiation in standard medium after treatment with effectors of cAMP metabolism. These findings suggest that cAMP is a potent stimulator for the fusion of cytotrophoblasts to form syncytiotrophoblasts. Therefore, we examined the changes in GLUT1 and GLUT3 levels during cAMP-induced differentiation using BeWo cells. We demonstrated that incubation of BeWo cells with 8-bromo-cAMP induced a significant increase in the GLUT1 level (Figs 6 and 7) with functional differentiation indicated by the increased hCG secretion. The amount of GLUT3 did not significantly change following treatment with 8-bromo-cAMP (Figs 6 and 7), although GLUT3 was expressed not only in the undifferentiated but also in the functionally differentiated BeWo cells (Figs 6 and 7) . After the treatment with 8-bromo-cAMP, syncytiotrophoblasts were found to be sparse (about 5% of cells in the 8-bromo-cAMP-treated group) (data not shown) and the majority of cells seemed to be cytotrophoblast-like mononuclear cells. These phenomena suggested that 8-bromocAMP stimulated functional rather than morphological differentiation in BeWo cells. In a previous report, cytotrophoblasts purified from human term placenta did not Figure 7 Immunoblot analysis of GLUT1 and GLUT3 in BeWo cells from control (lanes 1, 3) and 8-bromo-cAMP-treated (lanes 2, 4) cells. Cells were incubated in the absence or presence of 250 mol/l 8-bromo-cAMP for 2 days. Protein (50 g) extracted from cells was applied to 10% SDS-polyacrylamide gel and transferred to a nitrocellulose filter. The filter was incubated with rabbit anti-GLUT1 antiserum (lanes 1, 2) or with rabbit anti-GLUT3 antiserum (lanes 3, 4). Anti-GLUT1 and anti-GLUT3 antisera were used at a dilution of 1:3000 and 1:500 respectively. The positions of molecular markers are indicated on the left (in kb). When the filter was incubated with a non-immune serum, no specific bands were observed (data not shown). The data from representative experiments are shown. The experiment was repeated three times with similar results.
aggregate to form syncytia, in spite of a significant increase in hCG secretion induced by 8-bromo-cAMP in a serumfree medium (Feinman et al. 1986 ). These results suggest that the functional differentiation of trophoblast induced by 8-bromo-cAMP is not accompanied by morphological differentiation under serum-free conditions. In contrast, BeWo cells showed a morphological differentiation as shown by an increase in hCG secretion, in response to forskolin and theophyline in serum-supplemented conditions (Wice et al. 1990) . The discrepancy between the previous study and ours may come from the different serum concentrations in the culture media.
There was a significant increase not only in the hCG but also in the GLUT1 level after treatment with 8-bromo-cAMP. These results led us to speculate that the increase in the GLUT1 level induced by 8-bromo-cAMP is mainly associated with the functional differentiation. The reason why we could not detect a significant change in the GLUT3 level during trophoblast differentiation was unclear. However, it may be due to the fact that BeWo cells, in general, are not fully differentiated since they do not produce human placental lactogen (Madersbacher et al. 1998) or due to the possibility that the change of GLUT3 level in BeWo cell is not associated with differentiation. The effect of the increase in intracellular cAMP on the stimulation of glucose uptake was substantiated by the finding that treatment with both cholera toxin and forskolin had similar effects to that of 8-bromo-cAMP on 2-deoxyglucose uptake. These results suggest that 8-bromo-cAMP plays an important role in regulating glucose uptake and GLUT1 expression in BeWo cells.
Treatment with 8-bromo-cAMP had no significant effect on leucine and serotonin uptake (data not shown). The molecular mechanisms responsible for the specific stimulation of glucose uptake and GLUT1 expression by 8-bromo-cAMP in BeWo cells are not fully understood. Kaestner et al. (1991) reported that cAMP caused the transcriptional stimulation of the GLUT1 gene in 3T3-L1 adipocytes within 2-16 h. This result suggests that cAMP directly modulates the GLUT1 levels in 3T3-L1 adipocytes. Another study demonstrated that cAMP stimulates the transcriptional activity of the GLUT1 promoter in rat myoblasts and that a 33 bp sequence lying 5 upstream of the transcription start site was important for the 8-bromo-cAMP effects (Vinals et al. 1997 ). In our previous study, it was found that 8-bromo-cAMP inhibited 2-deoxyglucose uptake and the GLUT1 mRNA level in a primary mouse placental cell culture . The discrepancy between the findings in mice and those of the present study in humans may come from the different effects of cAMP on the GLUT1 level between species.
Further investigation is necessary to clarify the molecular mechanisms responsible for the regulation of the GLUT1 gene by cAMP in mouse and human placental cells, including the transcriptional regulation by cAMP.
